↧
Image may be NSFW.
Clik here to view.
Clik here to view.
CEL-SCI on cusp of cancer game-changer
After a decades-long odyssey, with plenty of bumps along the way, CEL-SCI (AMEX:CVM) of Vienna, Va. has begun the final clinical lap with its Multikine immunotherapy that could turn into a paradigm...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Hadasit Bio taps hotbed of innovation at Israel hospital
Hadasit Bio-Holdings (OTCBB: HADSY; TASE: HDST), operating as the technology transfer financing arm of Israel’s Hadassah Medical Center, has built a portfolio of promising, early-stage biotech...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
BioSante PK study adds to LibiGel safety and efficacy confidence
CEO Stephen M. Simes BioSante Pharmaceuticals’ (NASDAQ:BPAX) successful pharmacokinetic study of its LibiGel (testosterone gel) treatment for female sexual dysfunction, specifically hypoactive sexual...
View Article